These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 31585474)

  • 21. Assessment of the practical impact of adjusting beta-lactam dosages based on therapeutic drug monitoring in critically ill adult patients: a systematic review and meta-analysis of randomized clinical trials and observational studies.
    Gulyás E; Horváth IL; Engh MA; Bunduc S; Dembrovszky F; Fehérvári P; Bánvölgyi A; Csupor D; Hegyi P; Karvaly GB
    Sci Rep; 2024 Apr; 14(1):7793. PubMed ID: 38565898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Covariate determinants of effective dosing regimens for time-dependent beta-lactam antibiotics for critically ill patients.
    Kaska M; Havel E; Selke-Krulichova I; Safranek P; Bezouska J; Martinkova J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2018 Sep; 162(3):219-226. PubMed ID: 29582860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimization of the treatment with beta-lactam antibiotics in critically ill patients-guidelines from the French Society of Pharmacology and Therapeutics (Société Française de Pharmacologie et Thérapeutique-SFPT) and the French Society of Anaesthesia and Intensive Care Medicine (Société Française d'Anesthésie et Réanimation-SFAR).
    Guilhaumou R; Benaboud S; Bennis Y; Dahyot-Fizelier C; Dailly E; Gandia P; Goutelle S; Lefeuvre S; Mongardon N; Roger C; Scala-Bertola J; Lemaitre F; Garnier M
    Crit Care; 2019 Mar; 23(1):104. PubMed ID: 30925922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic Drug Monitoring of Beta-Lactams and Other Antibiotics in the Intensive Care Unit: Which Agents, Which Patients and Which Infections?
    Muller AE; Huttner B; Huttner A
    Drugs; 2018 Mar; 78(4):439-451. PubMed ID: 29476349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic Drug Monitoring of Antibiotics in Critically Ill Patients: Current Practice and Future Perspectives With a Focus on Clinical Outcome.
    Koch BCP; Muller AE; Hunfeld NGM; de Winter BCM; Ewoldt TMJ; Abdulla A; Endeman H
    Ther Drug Monit; 2022 Feb; 44(1):11-18. PubMed ID: 34772892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simultaneous determination of nine β-lactam antibiotics in human plasma by an ultrafast hydrophilic-interaction chromatography-tandem mass spectrometry.
    Abdulla A; Bahmany S; Wijma RA; van der Nagel BCH; Koch BCP
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():138-143. PubMed ID: 28618388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and pharmacodynamics of beta-lactam antibiotics in critically ill patients.
    Sulaiman H; Roberts JA; Abdul-Aziz MH
    Farm Hosp; 2022 Mar; 46(3):182-190. PubMed ID: 36183212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prolonged infusion of beta-lactam antibiotics for Gram-negative infections: rationale and evidence base.
    Abdul-Aziz MH; Portunato F; Roberts JA
    Curr Opin Infect Dis; 2020 Dec; 33(6):501-510. PubMed ID: 33009140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dose optimization of β-lactam antibiotics in children: from population pharmacokinetics to individualized therapy.
    Ngougni Pokem P; Vanneste D; Schouwenburg S; Abdulla A; Gijsen M; Dhont E; Van der Linden D; Spriet I; De Cock P; Koch B; Van Bambeke F; Wijnant GJ
    Expert Opin Drug Metab Toxicol; 2024 Aug; 20(8):787-804. PubMed ID: 39078238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficiency of dosing software using Bayesian forecasting in achieving target antibiotic exposures in critically ill patients, a prospective cohort study.
    Chai MG; Roberts JA; Kelly CF; Ungerer JPJ; McWhinney BC; Lipman J; Farkas A; Cotta MO
    Anaesth Crit Care Pain Med; 2023 Dec; 42(6):101296. PubMed ID: 37579945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibiotic Stewardship and Therapeutic Drug Monitoring of β-Lactam Antibiotics: Is There a Link? An Opinion Paper.
    Richter DC; Heininger A; Chiriac U; Frey OR; Rau H; Fuchs T; Röhr AC; Brinkmann A; Weigand MA
    Ther Drug Monit; 2022 Feb; 44(1):103-111. PubMed ID: 34857694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bacterial sepsis : Diagnostics and calculated antibiotic therapy.
    Richter DC; Heininger A; Brenner T; Hochreiter M; Bernhard M; Briegel J; Dubler S; Grabein B; Hecker A; Kruger WA; Mayer K; Pletz MW; Storzinger D; Pinder N; Hoppe-Tichy T; Weiterer S; Zimmermann S; Brinkmann A; Weigand MA; Lichtenstern C
    Anaesthesist; 2019 Feb; 68(Suppl 1):40-62. PubMed ID: 29383395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beta-Lactam Antibiotic Therapeutic Drug Monitoring in Critically Ill Patients: A Systematic Review and Meta-Analysis.
    Pai Mangalore R; Ashok A; Lee SJ; Romero L; Peel TN; Udy AA; Peleg AY
    Clin Infect Dis; 2022 Nov; 75(10):1848-1860. PubMed ID: 35731853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Failure of target attainment of beta-lactam antibiotics in critically ill patients and associated risk factors: a two-center prospective study (EXPAT).
    Abdulla A; Dijkstra A; Hunfeld NGM; Endeman H; Bahmany S; Ewoldt TMJ; Muller AE; van Gelder T; Gommers D; Koch BCP
    Crit Care; 2020 Sep; 24(1):558. PubMed ID: 32933574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How to optimize antibiotic pharmacokinetic/pharmacodynamics for Gram-negative infections in critically ill patients.
    Heffernan AJ; Sime FB; Taccone FS; Roberts JA
    Curr Opin Infect Dis; 2018 Dec; 31(6):555-565. PubMed ID: 30299354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. β-Lactam Therapeutic Drug Monitoring in Critically Ill Patients: Weighing the Challenges and Opportunities to Assess Clinical Value.
    Dilworth TJ; Schulz LT; Micek ST; Kollef MH; Rose WE
    Crit Care Explor; 2022 Jul; 4(7):e0726. PubMed ID: 35815181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The clinical application of beta-lactam antibiotic therapeutic drug monitoring in the critical care setting.
    Pai Mangalore R; Peel TN; Udy AA; Peleg AY
    J Antimicrob Chemother; 2023 Oct; 78(10):2395-2405. PubMed ID: 37466209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Empirical models for dosage optimization of four beta-lactams in critically ill septic patients based on therapeutic drug monitoring of amikacin.
    Delattre IK; Musuamba FT; Verbeeck RK; Dugernier T; Spapen H; Laterre PF; Wittebole X; Cumps J; Taccone FS; Vincent JL; Jacobs F; Wallemacq PE
    Clin Biochem; 2010 Apr; 43(6):589-98. PubMed ID: 20036226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experience with Implementing a Beta-lactam Therapeutic Drug Monitoring Service in a Burn Intensive Care Unit: A Retrospective Chart Review.
    Alshaer M; Mazirka P; Burch G; Peloquin C; Drabick Z; Carson J
    J Burn Care Res; 2023 Jan; 44(1):121-128. PubMed ID: 35896122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implementation of a β-lactam therapeutic drug monitoring program: Experience from a large academic medical center.
    Venugopalan V; Hamza M; Santevecchi B; DeSear K; Cherabuddi K; Peloquin CA; Alshaer MH
    Am J Health Syst Pharm; 2022 Sep; 79(18):1586-1591. PubMed ID: 35704702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.